Extension without change of a currently approved collection
No
Regular
06/14/2022
Requested
Previously Approved
36 Months From Approved
07/31/2022
14
19
88
122
7,616
9,520
This information collection supports
implementation of section 524 of the Federal Food, Drug, and
Cosmetic Act. The statute provides FDA with authority for awarding
priority review vouchers for future applications to sponsors of
tropical disease product applications that meet the criteria
specified by the Act. We have also developed associated guidance
intended to explain to internal and external stakeholders how we
implement the provisions of section 524.
Based on our evaluation of the
information collection since the last OMB review and approval, the
burden estimate decreased by 34 hours based on receipt of fewer
vouchers request and other information collection activities.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.